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Introduction {#sec005}
============

Tuberculosis (TB) is still a major global health problem and has been identified in the Sustainable Development Goals as one of the major diseases to be eliminated by 2030. Recent estimates from World Health Organization (WHO) give the global prevalence of TB as 174/100,000 and the incidence as 133/100,000 \[[@pone.0176581.ref001]\].

Despite China having a much lower prevalence (89/100,000) and incidence (68/100,000), there were still 1,200,000 TB cases and 930,000 incident TB cases in 2015. This accounted for almost 10% of the estimated new cases worldwide \[[@pone.0176581.ref001]\]. China therefore has one of the highest burdens of TB globally.

Passive case finding (PCF) and treatment of diagnosed TB disease are currently the principal means globally and in China, of controlling transmission of *Mycobacterium tuberculosis* and reducing TB incidence \[[@pone.0176581.ref002],[@pone.0176581.ref003]\]. The standard PCF approach has not been successful in detecting all cases and globally it has been estimated that nearly 37% of new TB cases are undiagnosed or not reported \[[@pone.0176581.ref001]\].

Active case finding (ACF) is believed to contribute to the earlier detection of persons with TB and an earlier initiation of treatment, and to result in better outcomes for individuals with reduced transmission in the community \[[@pone.0176581.ref004]--[@pone.0176581.ref006]\]. Almost all ACF interventions rely on sputum smear-microscopy as the basis for diagnosis; but there is also growing evidence that screening through the use of chest radiographs is both effective and cost-effective in high-burden settings \[[@pone.0176581.ref007],[@pone.0176581.ref008]\].

The results of most ACF studies show a predictable rise in the number of TB cases identified \[[@pone.0176581.ref009],[@pone.0176581.ref010]\]. However, the individual and community-level benefits from active screening for TB disease remain uncertain, and the benefits of earlier diagnosis on patient outcomes and on-going TB transmission have not yet been established \[[@pone.0176581.ref011]\].

WHO recently published operational guidelines on systematic screening for active tuberculosis \[[@pone.0176581.ref012],[@pone.0176581.ref013]\]. These have been developed for use in settings with different diagnostic resources, and they acknowledge that the yield (number of new cases of PTB found by each screening algorithm) will vary depending on the prevalence of undiagnosed TB and will be greater in subgroups at higher risk of TB. The prioritization of high risk groups for screening should be based on potential benefits and harms, the feasibility of the initiative, the acceptability of the approach, the number needed to screen, and the cost of screening\[[@pone.0176581.ref012],[@pone.0176581.ref013]\].

In China, the population of persons aged 65 years and over is rapidly expanding. They are at increased risk of TB due to a longer exposure to infection with *Mycobacterium tuberculosis* and declining immunity with age which allows latent infection to reactivate and cause disease\[[@pone.0176581.ref014],[@pone.0176581.ref015]\]. Those 60 years and over have a high prevalence of TB (349/100,000). This is 2.6 times higher than those aged 45 to 59 \[[@pone.0176581.ref016]\]. Symptoms of TB may be non-specific or absent, and attendance at health facilities may be erratic \[[@pone.0176581.ref017]\].

The aim of our study was to compare four screening algorithms for TB in persons aged 65 years and over. Using data from a TB prevalence study conducted in China, we sought to identify the risk groups with the highest yield and determine the relative costs of the different algorithms.

Methods {#sec006}
=======

Ethical considerations {#sec007}
----------------------

The prevalence study was reviewed and approved by the Institutional Review Board of Chinese Center for Disease Control and Prevention before commencing data collection. This study using data collected in the prevalence study, was approved by the Ethics Advisory Group of the International Union against Tuberculosis and Lung Disease, Paris, France.

Study design {#sec008}
------------

This was an analytic study based on data from a cross-sectional study.

Study setting {#sec009}
-------------

China has a population of 1.37 billion, of whom 10.1% are people aged 65 years or over, and a GDP per capita of \$7590 \[[@pone.0176581.ref018]\]. The level of affluence and urbanization varies greatly across the country.

There is a National TB control program (NTP) which develops the national protocols for detection and treatment of TB. The diagnosis of TB, including microscopy and X-ray examination, first-line anti-TB drugs and DOTS are all offered free of cost.

Study population {#sec010}
----------------

All persons aged 65 years and over who were interviewed in the TB prevalence study were included in the study.

TB prevalence survey {#sec011}
--------------------

A TB prevalence survey in adults was conducted in 2013, the results of which will be published in full elsewhere. Sample size was estimated using a method appropriate to estimate a single population proportion. The 369/100,000 prevalence of bacteria-positive PTB among elderly people (≥65 years) from the latest national tuberculosis prevalence survey was used as a reference. 95% confidence level and 0.2 allowable error were assumed. The formula was *n* = *pq*/(*d*/z~α~)^2^ (p = 369/100,000, q = 1-p, d = 0.2p,α = 0.05, *Z*~α~ = 1.96,). A total of 25,931 elderly participants were requested. In consideration of 10% non-response, sample size should be 28,812.

Multi-stage cluster sampling was used, and the procedure of sampling is shown in [Fig 1](#pone.0176581.g001){ref-type="fig"}. 27 study fields (10 townships and 17 communities) from 10 counties of 10 provinces were selected. The 10 counties are shown in [Fig 2](#pone.0176581.g002){ref-type="fig"}. The chosen number of townships or communities of each county depended on the population of aged people. Finally, 38,888 participants were included in the study.

![The sampling procedure of the TB prevalence survey in China in 2013.\
(\*) 10 out of 31 provinces were selected, by considering the cooperative willingness, human resources and related abilities of each province.](pone.0176581.g001){#pone.0176581.g001}

![The location of 10 sample counties in the TB prevalence survey in China in 2013.](pone.0176581.g002){#pone.0176581.g002}

Within this survey, each resident aged over 65 years was interviewed by trained staff face-to-face in their home using a standard questionnaire. Data on participants' sex, age, marital status, education, past medical history, occupation, tobacco and alcohol use were collected. Their height and weight were used to calculate their Body Mass Index (BMI).

All participants were invited to have a full-size chest X-ray (CXR). Participants who had any suspected TB symptoms (cough for over 2 weeks or haemopytsis) or abnormal lung field shadows on CXR, were requested to submit 3 sputum samples (morning, night and spot sputum). The sputum samples were submitted and examined by smear microscopy for acid-fast bacilli and were assessed for mycobacterial culture using the solid Löwenstein---Jensen medium.

The cost of each component of the screening process is shown in [Table 1](#pone.0176581.t001){ref-type="table"}. The cost of the household visits was based on the additional daily allowance, agreed nationally for work relating to infectious diseases, divided by the average number of households visited in a day. The price of a CXR, sputum smear and culture was the average market price paid.

10.1371/journal.pone.0176581.t001

###### Cost of each component of active TB case-finding in this study in China in 2013.

![](pone.0176581.t001){#pone.0176581.t001g}

  Contents                                                Cost per unit (USD)
  ------------------------------------------------------- ---------------------
  Household primary screening by village health workers   0.15
  Chest X-ray                                             9.0
  Sputum smear                                            3.9
  Sputum culture                                          4.8

Pulmonary TB was diagnosed as sputum smear-positive and/or culture positive, or it was diagnosed on CXR based on a decision by a group of clinical doctors and radiologists \[[@pone.0176581.ref016]\]. Quality checks were done according to the National Guidelines \[[@pone.0176581.ref019]\].

The data collected in the survey were double entered using an online input system developed by a local software company.

TB screening algorithms {#sec012}
-----------------------

WHO has published three different algorithms for use depending on the risk groups and the diagnostic resources available \[[@pone.0176581.ref012]\]. These WHO algorithms (A1, A1b, A2 and A3) are shown in [Table 2](#pone.0176581.t002){ref-type="table"}. Algorithm A1b is similar to A1 but is altered to reflect national policy in China which is to screen those with cough for more than 2 weeks and/or haemoptysis, rather than cough alone.

10.1371/journal.pone.0176581.t002

###### Algorithms to screen the population for TB aged 65 or over in the different high risk group in this study, based on the WHO recommendations.
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  Algorithms                                                                                       Intervention 1                                           Intervention 2     Intervention 3     Intervention 4
  ------------------------------------------------------------------------------------------------ -------------------------------------------------------- ------------------ ------------------ ----------------
  WHO A1                                                                                           Interview                                                CXR                Smear              Culture
  If cough lasting \> 2 weeks, then                                                                If positive, then                                        If positive = TB   If positive = TB   
  If negative, then                                                                                If negative, then possible clinical diagnosis with CXR                                         
  WHO A1b                                                                                          Interview                                                CXR                Smear              Culture
  If cough lasting \> 2 weeks &/or haemoptysis, then                                               If positive, then                                        If positive = TB   If positive = TB   
  If negative, then                                                                                If negative, then possible clinical diagnosis with CXR                                         
  WHO A2                                                                                           Interview                                                CXR                Smear              Culture
  If any TB symptoms(cough of any duration, haemoptysis, weight loss, fever, night sweats), then   If positive, then                                        If positive = TB   If positive = TB   
  If negative, then                                                                                If negative, then possible clinical diagnosis with CXR                                         
  WHO A3                                                                                           CXR                                                      Smear              Culture            NA
  If positive, then                                                                                If positive = TB                                         If positive = TB                      
  If negative, then                                                                                If negative, then possible clinical diagnosis with CXR                                         

The high risk groups \[[@pone.0176581.ref012]\] for TB identified from the literature are shown in [Table 3](#pone.0176581.t003){ref-type="table"}.

10.1371/journal.pone.0176581.t003

###### Definition of high risk factors for TB used in this study.
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  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Previous TB cases**: registered in TB Management Information System, and finished treatment or cured.
  **HIV/AIDS**: registered in local CDC database.
  **Known Diabetes**: recorded on the Citizen Health Management Files as diagnosed with Diabetes, plus those using medicine to control Blood glucose by self-report.
  **Close Contacts**: living with new active PTB case for at least 7 days in the three months before diagnosis.
  **BMI\<18.5**: Weight (kg)/Height2 (m2) \<18.5.
  **Tobacco use**: ever smoked tobacco by self-report.
  **Drinking history**: drinking more than one unit (21 grams pure alcohol) per week.
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

Data analysis {#sec013}
-------------

We obtained the point prevalence (number of missing TB cases detected/ population screened) data from the TB prevalence study and transferred this into our electronic database. For each algorithm and for different high risk groups, we calculated the yield of TB screening.

Yield = number new TB cases (smear-positive PTB, culture-positive PTB and active TB)

Number needed to screen to detect one case (NNS) = total number screened / number of cases identified

The costs of each of the algorithms were applied to the number of TB cases diagnosed to give indicative costs per case of TB detected: this was done by dividing the relative total cost of the tests in the algorithm by the number of new cases of TB identified.

All tests were performed using SAS 9.3 (SAS Institute Inc., USA).

Results {#sec014}
=======

From the TB prevalence survey, there were 38,888 eligible people aged 65 years and over in the ten sample areas. Demographic characteristics are shown in [Table 4](#pone.0176581.t004){ref-type="table"}.

10.1371/journal.pone.0176581.t004

###### Demographic characteristics of the population aged 65 or over in the sample population in China in 2013.
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  Characteristics          No.      \%
  ------------------------ -------- -------
  **Total**                38,888   100.0
  **Sex**                           
  Male                     18,005   46.3
  Female                   20,883   53.7
  **Age group**                     
  65--74                   24,102   62.0
  75--84                   12,193   31.3
  85-                      2,593    6.7
  **Place of residence**            
  Urban                    13,533   34.8
  Rural                    25,355   65.2

Nineteen people were excluded as they were known TB cases under treatment. 4,619 refused to participate. 34,250 (88.1%) agreed to participate in this study. Of those who agreed to participate 33,510 (97.8%) had a chest X-ray, and 1,534 submitted sputum for smear and culture.

The number of people diagnosed with TB by smear and/or culture is shown in [Table 5](#pone.0176581.t005){ref-type="table"}. There were 172 new TB cases, of which 116 were diagnosed only by CXR and clinical diagnosis.

10.1371/journal.pone.0176581.t005

###### Total number of new TB cases found in the study population in China in 2013 and how diagnosed, smear positive TB and/or culture positive TB, or CXR and clinical alone.
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               culture   Total   
  ------- ---- --------- ------- -----
  Smear   \+   23        8       31
  \-      25   116       141     
  Total        48        124     172

The number, yield, and prevalence of new TB cases, in each risk group is shown in [Table 6](#pone.0176581.t006){ref-type="table"}. The prevalence of new TB cases in males was 3 times higher than in females. The prevalence rates in "previous TB" and "close contacts" were very high, 3,698 and 3,192/100,000 respectively. Also, the groups "BMI\<18.5" and "Tobacco use" had high prevalence of new TB cases. For all risk groups except "BMI\<18.5", the new TB case prevalence in "rural areas" was 2 to 3 times higher than that in "urban areas"

10.1371/journal.pone.0176581.t006

###### Number in each risk group, number of new TB cases diagnosed and, prevalence of new TB cases, in the prevalence survey China, 2013.
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  Groups                 Total   Urban areas   Rural areas                                     
  ---------------------- ------- ------------- ------------- ------- ---- ------ ------- ----- ------
  All aged 65 and over   34250   172           502           12932   34   263    21318   138   647
  Previous TB            595     22            3698          251     6    2390   344     16    4651
  Close contacts         94      3             3192          20      0    0      74      3     4054
  BMI\<18.5              3632    39            1074          931     9    967    2701    30    1111
  Tobacco use            6763    55            813           2168    12   554    4595    43    936
  Male                   16044   129           804           6044    25   414    10000   104   1040
  Alcohol use            6543    40            611           1907    6    315    4636    34    733
  Diabetes               2400    14            583           1306    3    230    1094    11    1006
  Female                 18206   43            236           6888    9    131    11318   34    300
  HIV/AIDS               1       0             0             0       0    ---    1       0     0

Two specimen groups at increased risk of TB were identified to run the WHO algorithms. Group 1 "medium risk" was a group of 12,006, with a prevalence (between 936/100,000 and 4,651/100,000). This medium risk group comprised those living in a "rural area", who were "men" or a "previous TB case", or were a "close TB contact" or a "BMI \<18.5" or "tobacco users".

Group 2 "high risk" totalled 668 people, comprised the groups with the highest prevalence (over 3,000/100,000), which were all "previous TB cases" and all "close TB contacts". ([Table 7](#pone.0176581.t007){ref-type="table"})

10.1371/journal.pone.0176581.t007

###### Risk group 1 and 2, and yield, and prevalence of new TB cases, for each group.
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  Groups                                                     No. in risk group   No. of new TB cases diagnosed   Prevalence of new TB cases (per 100,000)
  ---------------------------------------------------------- ------------------- ------------------------------- ------------------------------------------
  medium risk group 1[\*](#t007fn001){ref-type="table-fn"}   12006               119                             991
  high risk group 2[\*\*](#t007fn002){ref-type="table-fn"}   688                 25                              3,634

\*Group 1 medium risk: Living in a rural area and male, or previous TB, or close contacts, or BMI\<18.5, or tobacco use

\*\*Group 2 high risk: previous TB or close contacts.

The numbers of each tests used in the screening algorithm, number of new TB diagnosed and relative cost per case for each group are shown in [Table 8](#pone.0176581.t008){ref-type="table"}.

10.1371/journal.pone.0176581.t008

###### Number of tests to be taken, yield and cost per case for each algorithm of the medium risk group 1, high risk group 2 and all aged 65 and over.
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  Algorithms   Group 1[\*](#t008fn001){ref-type="table-fn"}   Group 2[\*\*](#t008fn002){ref-type="table-fn"}   All aged 65 and over                                                                                         
  ------------ ---------------------------------------------- ------------------------------------------------ ---------------------- ----- ----- ----- ----- ----- ----- ---- ---- ----- ------- ----- ----- ----- ------- -------
  WHO A1       366                                            74                                               62                     25    481   221   59    31    25    12   58   72    611     103   90    31    1,105   330
  WHO A1b      386                                            79                                               67                     26    462   221   61    32    26    12   58   74    643     110   97    32    1,071   331
  WHO A2       683                                            107                                              94                     29    414   298   97    41    35    12   58   108   1313    153   138   37    926     458
  WHO A3       11953                                          551                                              531                    116   104   963   677   160   154   24   29   309   33510   989   959   164   209     1,881

\*Group 1 medium risk: Living in a rural area and male, or previous TB, or close contacts, or BMI\<18.5, or tobacco use.

\*\*Group 2 high risk: previous TB or close contacts.

The yield for algorithms WHO 1, 1b and 2 increased slightly from 15% (25/172) to 17% (29/172) in the medium risk group with cost per case increasing from \$221 to \$298 and was unchanged in the high risk group, 7% (12/172) at a cost of between \$72 and \$108 per case. For all aged 65 and over, algorithms WHO 1, 1b and 2 found 18% (31/172) to 22% (37/172) at a cost of between \$330 and \$458 per case.

WHO A3 diagnosed 67% (116/172), 14% (24/172) and 95% (164/172) of new TB cases respectively in two risk groups and all aged 65 and over, which were two and five times as many new TB cases as the other three algorithms, but the cost per case was three to five times higher at \$963, \$309 and \$1,881 per case respectively.

Discussion {#sec015}
==========

This is the first study that has applied the WHO TB algorithms to population data of a country. The study discussed the yield and relative cost per case when each algorithm was applied on a population aged 65 years and over.

The prevalence survey demonstrates the difficulty of screening 100% of a population. Only 88% agreed to participate and of those a small proportion did not attend to have a CXR.

Using the WHO algorithms, the NNS and the cost per case detected, varies depending on the prevalence in risk groups and which algorithm is used. But the lower cost per case detected may leave up to 93% of new cases undetected.

Using CXR as the first screening test as in algorithm WHO A3 in the medium risk group detects a much higher proportion of the new TB cases in the whole population (116/ 172) than the other algorithms (25 to 29/172) at a cost of \$963 per case.

The strengths of this study were that it used a large dataset collected as part of a carefully designed and implemented survey, which used the current TB diagnostic protocols and tests in China for diagnosis. Using real data to model the WHO algorithms showed how they work in practice. The study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines \[[@pone.0176581.ref020]\] and sound ethics principles for the conduct and reporting of this study \[[@pone.0176581.ref021]\].

The study had a few limitations. The costing data that was collected was basic and was only indicative of the relative costs of the different groups being screened. Only current occupation was recorded and most participants were retired, thus risk groups based on previous occupation could not be identified. The original prevalence survey identified 172 new cases of TB and this has been used in this study. This is likely be incorrect for several reasons 1) the reported sensitivity of CXR as a screening tool is 87% and the specificity 89% \[[@pone.0176581.ref012]\]. 2) There will also be false positives included particularly as 67% of the new diagnoses were not confirmed by smear or culture. 3) Only 88% of the target population was screened. In our study, no modeling of screening of people living with HIV was possible, as in the data there was only one person who was living with HIV.

Screening the high risk group only, of "previous TB cases" and "close contacts", gives a low cost per case. Studies from Africa and Cambodia also confirmed it was cost-effective to implement ACF among close contacts but the proportion of undiagnosed cases detected in the population is only 7% \[[@pone.0176581.ref022],[@pone.0176581.ref023]\]. If the End TB target is to be achieved this is not effective.

It is being argued that the Stop TB proposal of ACF costing \$350 per case \[[@pone.0176581.ref024]\] is too low to enable enough TB cases to be identified to reduce the prevalence in the community. It has been suggested that \$1000 per case is more realistic \[[@pone.0176581.ref024]\] and is more similar to the cost and benefit of ART.

Use of WHO algorithm 3 in China would detect 67% of the new cases in the elderly community, at a crude cost of under \$1000. The actual cost will be higher, but if the screening was set up as a large scale program the cost per test may well markedly reduce, for example with increased use of digital CXR \[[@pone.0176581.ref025]\].

The National Project of Basic Public Health Service launched by Ministry of Health in 2011 has made it easier for China to implement ACF \[[@pone.0176581.ref026]\]. In this project, all elderly people have an annual interview and physical examination, and the information recorded in the citizen health management file. This means that high risk groups as in [Table 2](#pone.0176581.t002){ref-type="table"} can be identified from routine data, and ACF can be combined with the annual physical examination. A pilot study in China, which integrated TB screening into annual health examinations for the rural elderly, and targeted diabetes patients and close contacts, had a significant yield. But no TB case was identified from close contacts alone \[[@pone.0176581.ref027]\].

China NTP used a different definition of TB symptoms from those in the WHO algorithm in that it uses "cough for 2 weeks or more, and haemoptysis". This was used in the algorithm WHO A1b. The study results found there was little difference in the number of cases detected from using cough alone. Three more cases were identified when weight loss, fever and night sweats were added in algorithm 2. This shows that it is not necessary to change the nationally agreed TB symptoms used for screening.

Algorithm WHO A1 and WHO A2, using symptoms as the initial screening, will miss many undiagnosed TB cases when implemented in China, but it can still be used in some resource-limited areas, such as Western China.

This study has implications for other TB high burden countries which are also resource-limited, such as India and Indonesia. Choosing the optimal ACF strategy depends on the TB prevalence, economics, and human resources, etc. and it needs to fit with local health policies and available technology. This study has shown how the yield varies greatly and higher costs may need to be accepted in order to have an impact on the burden of TB.

To achieve the ambitious targets of ending the TB epidemic by 2035, ACF screening has to be implemented more widely.

Conclusions {#sec016}
===========

WHO recommends that indiscriminate mass screening should be avoided, and the prioritization of risk groups for screening should be based on the prevalence of new cases \[[@pone.0176581.ref012]\]. Knowing the expected prevalence of TB in risk groups enables appropriate targeting of screening and in China risk groups can be identified from routine data. The cost per diagnosed case, and NNS increases as the prevalence reduces. However if just the highest risk groups are screened, only between 7 and 14% of the undetected cases will be found, depending on the algorithm used. To "End TB", appropriate medium risk groups will need to be screened. To obtain the highest yield, a CXR should be used for initial screening, as in WHO Algorithm 3.
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